A little over a year after Colossal Biosciences launched its nonprofit arm with $50 million in funding, the Colossal Foundation has doubled its capital with another $50 million in fundraising. In the ...
Colossal Biosciences is pulling one final surprise out of its hat in 2025. Announced today, the company’s nonprofit arm—The Colossal Foundation—secured an additional $50 million in funding, doubling ...
The Cities: Skylines franchise will soon be under new management following a split between publisher Paradox Interactive and developer Colossal Order. The parting of ways was announced on the Paradox ...
Knoepfler is STAT’s Lab Dish columnist and a professor of cell biology and human anatomy at UC Davis School of Medicine. De-extinction firm Colossal Biosciences announced Tuesday that it was acquiring ...
A team of astrophysicists has unveiled how colossal stars thousands of times more massive than the Sun shaped the earliest star clusters and galaxies. These short-lived giants not only forged the ...
ViaGen has successfully cloned endangered species like Przewalski’s horses. Elizabeth Arellano Photography/Courtesy Colossal Biosciences However, Colossal CEO Ben Lamm insists the move wasn’t ...
AUSTIN (KXAN) — An Austin-based company was acquired by Colossal Biosciences, a biosciences company that has claimed to “de-extinct” animals, according to a Tuesday announcement. Viagen Pets and ...
This business acquisition appears to be a genetic match: Colossal Biosciences, the company that brought back the dire wolves, has acquired Viagen Pets and Equine, which has cloned dogs for Paris ...
‘De-extinction’ startup Colossal Biosciences makes its first acquisition: a company that clones pets
The cloning industry is contracting—ironically, perhaps. On Tuesday, Colossal Biosciences announced that it has acquired ViaGen Pets and Equine, an animal cloning firm, marking Colossal’s first ...
Two Texas-based biotechnology companies are joining forces on a mission to reverse extinction. Colossal Biosciences Inc., the Dallas-based genetics company that claimed to have brought back the dire ...
Isabella Soares is a Senior Writer for Collider, as well as a Cherry Picks-approved critic. A film and TV enthusiast from an early age, Isabella used to write reviews in her journal growing up, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback